CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 369 shares at $51.74 ($19,092)
- 4 Open-market buy Director bought 500,000 shares at an average $42.92 ($21,459,736)
- 4 Open-market buy Director bought 351,273 shares at an average $39.19 ($13,765,345)
- 4 Open-market buy Director bought 1,205,147 shares at an average $38.84 ($46,806,729)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 2,172 shares at an average $65.19 ($141,595)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 392 shares at $65.19 ($25,555)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 8,818 shares at an average $63.17 ($557,051)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 46,933 shares at an average $63.17 ($2,964,841)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 17,179 shares at an average $76.80 ($1,319,291)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 5,706 shares at an average $76.80 ($438,203)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,280 shares at $86.75 ($111,045)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 3,678 shares at $86.75 ($319,059)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 1,986 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 3,404 shares (grant or award)
- 4 Open-market buy Director bought 169,521 shares at an average $79.40 ($13,460,090)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 6,187 shares at an average $78.61 ($486,370)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 25,459 shares at an average $78.61 ($2,001,371)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 287 shares at $77.52 ($22,248)
Page 2 of 22 · 438 filings